GB IMPLANTAT-TECHNOLOGIE GMBH – Trademark Portfolio

Entity Type: 03

GB IMPLANTAT-TECHNOLOGIE GMBH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ENDOCAST. The owner is based in ESSEN.

HARKORTSTRASSE 65

ESSEN D-45145 , DE

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ENDOCAST
ENDOCAST
Registered 1978

Trademark Classifications

GB IMPLANTAT-TECHNOLOGIE GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

Frequently Asked Questions

How many trademarks does GB IMPLANTAT-TECHNOLOGIE GMBH have?

GB IMPLANTAT-TECHNOLOGIE GMBH has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GB IMPLANTAT-TECHNOLOGIE GMBH file in?

GB IMPLANTAT-TECHNOLOGIE GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 6 (Metal Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GB IMPLANTAT-TECHNOLOGIE GMBH's most well-known trademarks?

GB IMPLANTAT-TECHNOLOGIE GMBH's registered trademark portfolio includes well-known marks such as ENDOCAST. These are among 1 currently registered trademark in the portfolio.

What is GB IMPLANTAT-TECHNOLOGIE GMBH's trademark registration success rate?

GB IMPLANTAT-TECHNOLOGIE GMBH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.